U.S. Biotechnology Instruments Market Size, Share & Trends Analysis Report By Product (Analytical Instruments, Cell Culture Instruments, Cell Separation Instruments), By End-use, And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation and Scope
                    1.2. Market Definitions
                        1.2.1. Product Segment
                        1.2.2. End-use Segment
                    1.3. Research Assumptions
                    1.4. Information Procurement
                        1.4.1. Primary Research
                    1.5. Information or Data Analysis
                    1.6. Market Formulation & Validation
                    1.7. Market Model
                    1.8. U.S. Market: CAGR Calculation
                    1.9. Objectives
Chapter 2. Executive Summary
                    2.1. Market Snapshot
                    2.2. Segment Snapshot
                    2.3. Competitive Landscape Snapshot
Chapter 3. Variables, Trends, & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent Market Outlook
                        3.1.2. Related/Ancillary Market Outlook
                    3.2. Market Trends and Outlook
                    3.3. Market Dynamics
                        3.3.1. Increasing Demand for Analytical Instruments
                        3.3.2. Growing Prevalence of Target Diseases and Rising Geriatric Population
                        3.3.3. Technological Advancements in Research-Use Instruments
                    3.4. Market Restraint Analysis
                        3.4.1. Higher Cost of Devices
                        3.4.2. Shortage Of Skilled Professionals
                    3.5. Business Environment Analysis
                        3.5.1. PESTEL Analysis
                        3.5.2. Porter’s Five Forces Analysis
                        3.5.3. COVID-19 Impact Analysis
Chapter 4. Product Business Analysis
                    4.1. Biotechnology Instruments Market: Product Movement Analysis
                    4.2. Analytical Instruments
                        4.2.1. Analytical Instruments Market, 2018 - 2030 (USD Million)
                        4.2.2. Polymerase Chain Reaction
                            4.2.2.1. Polymerase Chain Reaction, 2018 - 2030 (USD Million)
                        4.2.3. Spectroscopy
                            4.2.3.1. Spectroscopy, 2018 - 2030 (USD Million)
                        4.2.4. Microscopy
                            4.2.4.1. Microscopy, 2018 - 2030 (USD Million)
                        4.2.5. Chromatography
                            4.2.5.1. Chromatography, 2018 - 2030 (USD Million)
                        4.2.6. Flow Cytometry
                            4.2.6.1. Flow Cytometry, 2018 - 2030 (USD Million)
                        4.2.7. Sequencing
                            4.2.7.1. Sequencing, 2018 - 2030 (USD Million)
                        4.2.8. Microarray
                            4.2.8.1. Microarray, 2018 - 2030 (USD Million)
                        4.2.9. Others
                            4.2.9.1. Others, 2018 - 2030 (USD Million)
                    4.3. Cell Culture Instruments
                        4.3.1. Cell Culture Instruments Market, 2018 - 2030 (USD Million)
                        4.3.2. Culture Systems
                            4.3.2.1. Culture Systems Market, 2018 - 2030 (USD Million)
                        4.3.3. Incubators
                            4.3.3.1. Incubators Market, 2018 - 2030 (USD Million)
                        4.3.4. Cryostorage Equipment
                            4.3.4.1. Cryostorage Equipment Market, 2018 - 2030 (USD Million)
                        4.3.5. Biosafety Equipment
                            4.3.5.1. Biosafety Equipment Market, 2018 - 2030 (USD Million)
                        4.3.6. Pipetting Instruments
                            4.3.6.1. Pipetting Instruments Market, 2018 - 2030 (USD Million)
                    4.4. Cell Separation Instruments
                        4.4.1. Cell Separation Instruments Market, 2018 - 2030 (USD Million)
                        4.4.2. Centrifuge
                            4.4.2.1. Centrifuge Market, 2018 - 2030 (USD Million)
                        4.4.3. Filtration Systems
                            4.4.3.1. Filtration Systems Market, 2018 - 2030 (USD Million)
                        4.4.4. Magnetic-activated Cell Separator Systems
                            4.4.4.1. Magnetic-activated Cell Separator Systems Market, 2018 - 2030 (USD Million)
                    4.5. Immunoassay Instruments
                        4.5.1. Immunoassay Instruments Market, 2018 - 2030 (USD Million)
                    4.6. Clinical Chemistry Analyzers
                        4.6.1. Clinical Chemistry Analyzers Market, 2018 - 2030 (USD Million)
                    4.7. Others
                        4.7.1. Others Market, 2018 - 2030 (USD Million)
Chapter 5. End-use Business Analysis
                    5.1. Biotechnology Instruments Market: End-use Movement Analysis
                    5.2. Pharmaceutical & Biotechnology Companies
                        5.2.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
                    5.3. Hospitals & Diagnostic Laboratories
                        5.3.1. Hospitals & Diagnostics Laboratories Market, 2018 - 2030 (USD Million)
                    5.4. Academic & Research Institutes
                        5.4.1. Academic & Research Institutes Market, 2018 - 2030 (USD Million)
                    5.5. Others
                        5.5.1. Others Market, 2018 - 2030 (USD Million)
Chapter 6. Competitive Landscape
                    6.1. Company Categorization
                    6.2. Strategy Mapping
                    6.3. Company Market Share Analysis, 2023
                    6.4. Company Profiles/Listing
                        6.4.1. Thermo Fisher Scientific, Inc.
                            6.4.1.1. Company Overview
                            6.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            6.4.1.3. Product Benchmarking
                            6.4.1.4. Strategic Initiatives
                        6.4.2. Waters Corp.
                            6.4.2.1. Company Overview
                            6.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            6.4.2.3. Product Benchmarking
                            6.4.2.4. Strategic Initiatives
                        6.4.3. Shimadzu Corp.
                            6.4.3.1. Company Overview
                            6.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            6.4.3.3. Product Benchmarking
                            6.4.3.4. Strategic Initiatives
                        6.4.4. Danaher
                            6.4.4.1. Company Overview
                            6.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            6.4.4.3. Product Benchmarking
                            6.4.4.4. Strategic Initiatives
                        6.4.5. Agilent Technologies, Inc.
                            6.4.5.1. Company Overview
                            6.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            6.4.5.3. Product Benchmarking
                            6.4.5.4. Strategic Initiatives
                        6.4.6. Bruker Corp.
                            6.4.6.1. Company Overview
                            6.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            6.4.6.3. Product Benchmarking
                            6.4.6.4. Strategic Initiatives
                        6.4.7. PerkinElmer, Inc.
                            6.4.7.1. Company Overview
                            6.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            6.4.7.3. Product Benchmarking
                            6.4.7.4. Strategic Initiatives
                        6.4.8. Mettler Toledo
                            6.4.8.1. Company Overview
                            6.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            6.4.8.3. Product Benchmarking
                            6.4.8.4. Strategic Initiatives
                        6.4.9. Zeiss Group
                            6.4.9.1. Company Overview
                            6.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            6.4.9.3. Product Benchmarking
                            6.4.9.4. Strategic Initiatives
                        6.4.10. Bio-Rad Laboratories, Inc.
                            6.4.10.1. Company Overview
                            6.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            6.4.10.3. Product Benchmarking
                            6.4.10.4. Strategic Initiatives
                        6.4.11. Illumina, Inc.
                            6.4.11.1. Company Overview
                            6.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            6.4.11.3. Product Benchmarking
                            6.4.11.4. Strategic Initiatives
                        6.4.12. Eppendorf SE
                            6.4.12.1. Company Overview
                            6.4.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            6.4.12.3. Product Benchmarking
                            6.4.12.4. Strategic Initiatives
                        6.4.13. F. Hoffmann-La Roche AG
                            6.4.13.1. Company Overview
                            6.4.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            6.4.13.3. Product Benchmarking
                            6.4.13.4. Strategic Initiatives
                        6.4.14. Sartorius AG
                            6.4.14.1. Company Overview
                            6.4.14.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            6.4.14.3. Product Benchmarking
                            6.4.14.4. Strategic Initiatives
                        6.4.15. Avantor, Inc.
                            6.4.15.1. Company Overview
                            6.4.15.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            6.4.15.3. Product Benchmarking
                            6.4.15.4. Strategic Initiatives

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviation
Table 3 U.S. biotechnology instruments market, by product, 2018 - 2030 (USD Million)
Table 4 U.S biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Market summary
Fig. 4 Market segmentation & scope
Fig. 5 Market size and growth prospects
Fig. 6 U.S. biotechnology instruments market - Key market driver analysis
Fig. 7 U.S. biotechnology instruments market - Key market restraint analysis
Fig. 8 U.S. biotechnology instruments market - Porter’s analysis
Fig. 9 U.S. biotechnology instruments market - PESTEL analysis
Fig. 10 U.S. biotechnology instruments market: Product outlook key takeaways
Fig. 11 U.S. biotechnology instruments market: Product movement analysis
Fig. 12 Analytical instruments market estimates, 2018 - 2030 (USD Million)
Fig. 13 Polymerase chain reaction market estimates, 2018 - 2030 (USD Million)
Fig. 14 Spectroscopy market estimates, 2018 - 2030 (USD Million)
Fig. 15 Microscopy market estimates, 2018 - 2030 (USD Million)
Fig. 16 Chromatography market estimates, 2018 - 2030 (USD Million)
Fig. 17 Flow cytometry market estimates, 2018 - 2030 (USD Million)
Fig. 18 Sequencing market estimates, 2018 - 2030 (USD Million)
Fig. 19 Microarray market estimates, 2018 - 2030 (USD Million)
Fig. 20 Others market estimates, 2018 - 2030 (USD Million)
Fig. 21 Cell culture instruments market estimates, 2018 - 2030 (USD Million)
Fig. 22 Culture systems market estimates, 2018 - 2030 (USD Million)
Fig. 23 Incubators market estimates, 2018 - 2030 (USD Million)
Fig. 24 Cryostorage equipment market estimates, 2018 - 2030 (USD Million)
Fig. 25 Biosafety equipment market estimates, 2018 - 2030 (USD Million)
Fig. 26 Pipetting instruments market estimates, 2018 - 2030 (USD Million)
Fig. 27 Cell separation instruments market estimates, 2018 - 2030 (USD Million)
Fig. 28 Centrifuge market estimates, 2018 - 2030 (USD Million)
Fig. 29 Filtration systems market estimates, 2018 - 2030 (USD Million)
Fig. 30 Magnetic-activated cell separator systems market estimates, 2018 - 2030 (USD Million)
Fig. 31 Immnuoassay instruments market estimates, 2018 - 2030 (USD Million)
Fig. 32 Clinical chemistry analyzers market estimates, 2018 - 2030 (USD Million)
Fig. 33 Others market estimates, 2018 - 2030 (USD Million)
Fig. 34 U.S. biotechnology instruments market: End-use outlook key takeaways
Fig. 35 U.S. biotechnology instruments market: End-use movement analysis
Fig. 36 Pharmaceutical & biotechnology companies market estimates, 2018 - 2030 (USD Million)
Fig. 37 Hospitals & diagnostic laboratories market estimates, 2018 - 2030 (USD Million)
Fig. 38 Academic & research institutes market estimates, 2018 - 2030 (USD Million)
Fig. 39 Others market estimates, 2018 - 2030 (USD Million)
Fig. 40 U.S. biotechnology instruments market, 2018 - 2030 (USD Million)